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Mice lacking the transcription factor NF-E2 p45-related factor 2 (Nrf2) develop more severe nonalcoholic steatohepatitis
(NASH), with cirrhosis, than wild-type (Nrf2/) mice when fed a high-fat (HF) diet for 24 weeks. Although NASH is usually
associated with insulin resistance, HF-fedNrf2/mice exhibited better insulin sensitivity than HF-fedNrf2/mice. In livers
of HF-fed mice, loss of Nrf2 resulted in greater induction of lipogenic genes, lower expression of -oxidation genes, greater re-
duction in AMP-activated protein kinase (AMPK) levels, and diminished acetyl coenzyme A (CoA) carboxylase phosphorylation
than in the wild-type livers, which is consistent with greater fatty acid (FA) synthesis inNrf2/ livers. Moreover, primary
Nrf2/ hepatocytes displayed lower glucose and FA oxidation thanNrf2/ hepatocytes, with FA oxidation partially rescued by
treatment with AMPK activators. The unfolded protein response (UPR) was perturbed in control regular-chow (RC)-fedNrf2/
mouse livers, and this was associated with constitutive activation of NF-B and JNK, along with upregulation of inflammatory
genes. The HF diet elicited an antioxidant response inNrf2/ livers, and as this was compromised inNrf2/ livers, they suf-
fered oxidative stress. Therefore, Nrf2 protects against NASH by suppressing lipogenesis, supporting mitochondrial function,
increasing the threshold for the UPR and inflammation, and enabling adaptation to HF-diet-induced oxidative stress.
Nonalcoholic fatty liver disease (NAFLD) is a common condi-tion that is associated with obesity, type 2 diabetes mellitus,
and insulin resistance (1, 2). It represents a spectrum of pheno-
types ranging from simple steatosis (fatty infiltration) through
nonalcoholic steatohepatitis (NASH) to fibrosis and ultimately
cirrhosis. However, the molecular events that dictate the evolu-
tion of NASH are not well defined (3).
Consumption of a high-fat (HF) diet, or excess lipogenesis, can
lead to endoplasmic reticulum (ER) stress, which in turn stimu-
lates the unfolded protein response (UPR) that attenuates tran-
scriptional and translational programs to restore ER homeostasis
(4–6). Initiation of the UPR is carried out by activating transcrip-
tion factor 6 (ATF6), inositol-requiring enzyme 1 (IRE1), and
protein kinase RNA (PKR)-like ER kinase (PERK). If ER stress is
unresolved, ATF6, IRE1, and PERK stimulate lipogenesis by acti-
vating sterol regulatory element binding protein 1c (SREBP-1c),
X-box binding protein 1 (XBP1), CCAAT/enhancer-binding pro-
tein  (C/EBP), and eukaryotic initiation factor 2 (eIF2) (7–
10). Steatosis can arise during unresolved ER stress as a conse-
quence of upregulation of C/EBP homologous protein (CHOP)
because it suppresses the expression of key metabolic gene regu-
lators (11, 12).
Progression of liver steatosis to NASH requires the coexistence
of inflammation. NASH may develop in individuals with meta-
bolic syndrome because excessive delivery of fatty acids (FA) and
triglycerides to the liver leads to increased lipidmetabolism, caus-
ing oxidative stress through overproduction of reactive oxygen
species (ROS) (13). Oxidative stress activates nuclear factor B
(NF-B) and c-JunN-terminal kinase (JNK), leading to induction
of inflammatory genes, which in turn increase neutrophil recruit-
ment to the liver and exacerbate both oxidative stress and inflam-
mation (14). Besides oxidative stress, NF-B and JNK can also be
activated by ER stress (15, 16), and the fact that ER stress is accen-
tuated by ROS (17) indicates that inflammation in NAFLD is
probably inextricably connected with both ER and oxidative
stress. Once established, chronic inflammation results in induc-
tion of apoptotic genes via JNK/c-Jun signaling (14), which leads
to hepatocyte death and fibrosis (18).
The cap ’n’ collar (CNC) basic-region leucine zipper (bZIP)
transcription factor NF-E2 p45-related factor 2 (Nrf2, also called
Nfe2l2) enables cells to adapt to oxidative stress by transactivating
cytoprotective genes that contain antioxidant response element
(ARE) sequences in their promoters (19–21). Under nonstressed
conditions, Nrf2 activity is restricted by its constitutive protea-
somal degradation, which is mediated by Kelch-like ECH-associ-
ated protein 1 (Keap1), a cullin-3 ubiquitin ligase substrate adap-
tor (22–24). However, the ability of Keap1 to direct Nrf2 for
proteasomal degradation is blocked by thiol-reactive agents,
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which modify Cys residues in the substrate adaptor (25–27), re-
sulting in induction of ARE-driven genes that provide protection
against electrophiles and prooxidants (28).
Nrf2 may play a pivotal role in the development of NASH,
because it represses the expression of genes involved in FA synthe-
sis (29–31) and antagonizes inflammation (32). Global knockout
of Nrf2 profoundly increases the susceptibility of mice to NASH
when they are placed on a methionine- and choline-deficient
(MCD) diet (33, 34), whereas genetic activation of Nrf2 by knock-
down of Keap1 decreases their sensitivity to NASH caused by the
MCD diet (35). The MCD diet, however, is of limited value as a
model for human disease because it affects only the liver, produces
rapid weight loss, and does not cause insulin resistance, and there-
fore, challenge with an HF diet provides a more relevant means of
producing NAFLD experimentally. It is therefore notable that
Nrf2 has been shown to influence hepatic lipid metabolism in
HF-fed mice (36–44). Although the duration of HF diet feeding
has varied enormously in such studies, it has generally been found
that the livers ofNrf2/mice accumulate lipid to a greater extent
than those of wild-type mice. Some researchers have reported
greater expression of lipid metabolism-associated transcription
factors and lipid metabolism-associated enzymes/proteins in
Nrf2/mice than in the wild type, but consistent changes in gene
expression have not been observed across all studies. Further-
more, in accordance with the view that Nrf2 inhibits hepatic lipid
accumulation, pharmacological activation of Nrf2 has been found
to downregulate lipogenesis genes (37, 38, 45). Surprisingly, how-
ever, genetic activation of Nrf2 has been reported to increase ste-
atosis and inflammation in both leptin-deficient and HF-fed ani-
mals (46, 47), and it has been speculated that Keap1may influence
NASH by uncharacterized mechanisms that do not involve Nrf2.
Consistent with this hypothesis, evidence has been provided that
Keap1 suppresses activation of the JNK/c-Jun pathway by FA in an
Nrf2-independent manner (48).
The primary emphasis of all the HF diet studies in Nrf2/
mice outlined above has been on the expression of lipid metabo-
lism genes. Little is therefore known about how loss of Nrf2 affects
HF diet-stimulated ER stress and oxidative stress or how it influ-
ences the metabolic activity of hepatocytes. Moreover, the possi-
ble contribution of Nrf2 to insulin resistance during development
of NASH is unknown. Thus, during the present study, we exam-
ined whether knockout of Nrf2 produces peripheral insulin resis-
tance and whether this predicates increased sensitivity of the liver
to NASH upon feeding an HF diet. Moreover, we tested the hy-
pothesis that steatosis in livers of Nrf2/ mice fed an HF diet
disturbs the UPR and causes oxidative stress, both of which drive
inflammation.
MATERIALS AND METHODS
Animals. Throughout this study, malemice were examined. TheNrf2/
and Nrf2/ animals, created by Itoh et al. (49) and provided kindly by
Ken Itoh andMasayuki Yamamoto,were backcrossed over six generations
onto a C57BL/6 background as described previously (50). All animal care
protocols and procedures were performed in accordance to the Animal
Scientific Procedures Act (1986) and with the approval of the University
of Dundee Animal Ethics Committee. From 8 to 10 weeks of age, themice
were provided ad libitum either regular chow (RC), purchased from SDS
Ltd. (Witham, Essex, United Kingdom), or an HF diet, obtained from
Testdiets (International Product Supplies, London, United Kingdom).
The RC contained 7.5% fat by energy; the HF diet contained 45% fat by
energy. Fat mass, spontaneous locomotor activity, and food intake were
determined (typically onmice between 24 and 30 weeks of age, which had
been fed from the age of 8 to 10 weeks on either the HF diet or RC diet for
16 or 20 weeks) as described previously (51). For analysis of insulin sig-
naling (ex vivo), mice (typically 28 weeks of age) were subjected to an
overnight fast and injected with 2 units of insulin/kg body weight or an
equal volume of saline intraperitoneally. The quadriceps muscle and liver
were collected in liquid nitrogen 5 and 6 min after injection, respectively.
The vast majority of biochemical andmolecular biology analyses were
performed on livers ofNrf2/ andNrf2/mice that had been placed on
an RC or HF diet for 24 weeks (32 to 34 weeks of age). Upon sacrifice of
these animals, plasma was collected, and the livers were removed. A lobe
fromeach liverwas preserved in formalin for histological analyses, and the
remainder was snap-frozen in liquid nitrogen.
Physiological and clinical-chemistrymeasurements.The EchoMRI-
900 quantitative nuclear magnetic resonance (qMR) system (Echo Med-
ical Systems, Houston, TX) was used to determine fat mass and lean mass
in conscious mice. Blood samples were collected via tail vein or cardiac
puncture performed on terminally anesthetizedmice. Blood glucose, trig-
lycerides, cholesterol and free fatty acid, and plasma leptin and insulin
were measured as described previously (51). Plasma -hydroxybutyrate
was measured using a colorimetric assay (Cayman Chemical Company,
Ann Arbor, MI). Plasma alanine aminotransferase (ALT) activity was
measured using kits on a Daytona autoanalyzer (Randox). Glucose and
insulin tolerance tests were carried out on mice as described elsewhere
(51). The respiratory exchange ratio (RER) and O2 consumption were
determined by open-circuit indirect calorimetry (Columbus Instru-
ments).
Histology. Formalin-fixedmurine liver specimens were processed for
hematoxylin and eosin staining as described previously (33). The severity
of liver disease was evaluated histologically using the NAFLD activity
score (NAS), which is the standard system for reporting the extent of
damage (52); it represents the combined semiquantitated pathology score
for steatosis, inflammation, and hepatocyte ballooning.
Reticulin and Van Gieson’s staining of liver sections was undertaken
by standard methods. Staining for nitrotyrosine protein adducts was per-
formed as described previously (53), and a terminal deoxynucleotidyl
transferase-mediated dUTP-biotin nick end labeling (TUNEL) assay was
performed as described elsewhere (54). For electron microscopy analysis,
livers were fixed in 2.5% glutaraldehyde-4% paraformaldehyde in 0.1 M
sodium cacodylate buffer, postfixed in 1% aqueous osmium tetroxide,
dehydrated in ethanol, transferred to propylene oxide, and then embed-
ded in Durcupan resin (Sigma). Sections were cut on a Leica ultrami-
crotome and collected on Pioloform B (polyvinyl butyral)-coated copper
grids, stained with uranyl acetate and lead citrate, and examined in a Jeol
EX electron microscope. Images were collected on digital-imaging plates
and processed in a Ditabis (Pforzeim, Germany) scanner.
Antibodies. Antibodies against acetyl coenzyme A (CoA) carboxylase
(ACC), phosphorylated ACC (p-ACC), phosphorylated AMP-activated
protein kinase (p-AMPK), CHOP, cleaved caspase 3, cleaved caspase 9,
eIF, 78-kDa glucose-regulated protein (GRP78, also called BiP), high-
mobility group protein B1 (HMGB1), IRE1, PERK, JNK, and p-JNK
were purchased from Cell Signaling (Invitrogen). The antibodies against
activating transcription factor 4 (ATF4), pHistone H2AX, NF-B, and
procaspase 9 were obtained from Santa Cruz. The antibody against ATF6
was from Imgenex, and that against XBP1was fromAbcam. The antibody
against actin was from Sigma-Aldrich, and that against total AMPK (1
and 2 subunits) was from DSTT (University of Dundee). The antibody
against nitrotyrosine was from Millipore. Antisera against mouse gluta-
thione S-transferase a1 (Gsta1), mouse Gstm1, rat GSTA4, human gluta-
mate-cysteine ligase catalytic (GCLC) and modifier (GCLM) subunits,
and rat NAD(P)H:quinone oxidoreductase 1 (NQO1) were produced in
house (50, 55).
Biochemical analyses. Portions (approximately 100 mg) of frozen
mouse liver were pulverized individually under liquid nitrogen, using a
mortar and pestle. The ground material from each sample was resus-
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pended in 1 ml of ice-cold 50 mM HEPES buffer, pH 7.5, that contained
150 mMNaCl, 1 mM dithiothreitol, and protease inhibitors before being
homogenized. Thereafter, cytosol was prepared at 4°C from individual
livers after two centrifugation steps (15,000 g for 45min and 100,000
g for 90 min). For AMPK, ACC, and JNKWestern blots, whole-cell solu-
ble extracts were prepared from the resuspended material by a single cen-
trifugation step (15,000  g for 15 min at 4°C). For the NF-B Western
blots, nuclear extracts were prepared from frozen liver using the Pierce
NE-PER kit (ThermoScientific Life Science Research Products, Rockford,
IL). Protein concentrations in samples were measured as described previ-
ously, as were total glutathione, reduced glutathione (GSH), and oxidized
glutathione (GSSG) (33). Liver malondialdehyde (MDA) and protein ox-
idation levels were measured using a TBARS assay kit (Cayman Chemical
Company) and an OxyBlot detection kit (Millipore), respectively.
Gene expression profiling. The expression of hepatic genes in the
Nrf2/ andNrf2/mice fed an RC or HF diet was measured by TaqMan
real-time PCR using an Applied Biosystems Prismmodel 7700 sequence de-
tector instrument (50). mRNAs for the following classes of proteins were
monitored using commercial primer and probe sets, all of which were pur-
chased from Life Technologies: lipid-associated transcription factors (farne-
soid X receptor [FXR; Mm00436425_m1], liver X receptor alpha [LXR;
Mm00443451_m1], LXR [Mm00437265_g1], MLX-interacting protein-
like [Mlxipl, also called carbohydrate-responsive element binding protein
{ChERBP}; Mm00498811_m1], peroxisome proliferator-activated receptor
alpha [PPAR; Mm00440939_m1], PPAR [Mm01184322_m1], retinoid X
receptor alpha [RXR; Mm00441185_m1], small heterodimer partner [Shp;
Mm00442278_m1], Srebf1 [whose mRNA encodes Srebp-1c;
Mm00550338_m1], and Srebf2 [whose mRNA encodes Srebp-2;
Mm01306293_m1]), FA synthesis proteins (acetyl-CoA carboxylase alpha
[Acaca; Mm01304277_m1], ATP-citrate lyase [Acly; Mm01302282_m1],
elongation of very long-chain fatty acids protein 5 [Elovl5; Mm00506717_
m1], Elovl6 [Mm00851223_s1], and fatty acid synthase [Fasn;
Mm00662319_m1]), the FA desaturation enzyme stearoyl-CoA de-
saturase (Scd1; Mm00772290_m1), triglyceride assembly proteins
(fatty acid-binding protein 1 [Fabp1; Mm00444340_m1] and Fabp5
[Mm00783731_s1]), enzymes involved in FA oxidation (acetyl-CoA
acyltransferase 1 [Acaa1; Mm00728460_s1], acetyl-CoA carboxylase
beta [Acacb; Mm01204683_ml], carnitine palmitoyl-transferase [Cpt1a;
Mm00550439_m1], cytochrome P450 4a10 [Cyp4a10; Mm01188913_
g1], Cyp4a14 [Mm00484132_m1], and Cyp2e1 [Mm00491127_m1]), ER
stress proteins (Atf4 [Mm00515325_g1], Atf6 [Mm00520279_m1], Chop
[Mm01135937_g1], growth arrest and DNA-damage-inducible protein
34 [Gadd34; Mm01205601_g1], Grp78 [Mm00517690_g1], and Xbp1s
and Xbp1unspliced [56]), inflammation proteins (cyclooxygenase 2
[Cox2; Mm00478377_g1], interleukin-1 [IL-1; Mm99999061_mH],
IL-6 [Mmoo446190_m1], myeloperoxidase [Mpo; Mm01298424_m1], ni-
tric oxide synthase 2 [Nos2; Mm00440485_m1], NF-B p65 [RelA;
Mm00501346_m1], and tumor necrosis factor alpha [TNF-;
Mm00443259_g1]), antioxidant proteins (cystine/glutamate antiporter
light chain xCT [Slc7a11; Mm00442530_m1], Gclc [50], Gclm [50], sul-
firedoxin [Srxn1; Mm00769566_m1], and thioredoxin reductase [Tx-
nrd1; Mm00443675_m1]), drug-metabolizing enzymes (Gsta1 [50],
Gsta2 [50], Gsta4 [50], Gstm1 [50], and Gstm2 [50] subunits and Nqo1
[57]), and the general stress enzyme heme oxygenase 1 (Hmox1;
Mm00516006_m1).
Western blotting. Tissue proteins were resolved by SDS-PAGE in
10% polyacrylamide gels before they were transferred onto Immobilon-P
membranes. The immobilized polypeptideswere probedusing a variety of
commercial antibodies or in-house rabbit antiserum, and following ex-
tensivewashing of the blots, the cross-reacting bandswere identified using
horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG and visu-
alized by enhanced chemiluminescence (50, 55). Equal protein loading of
samples was assessed using glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), actin, or PCNA.
Cells. Primary hepatocytes were prepared from the livers of RC diet-
fed 10-week-old mice by the method of Foretz et al. (58). The livers were
first washed with perfusion buffer (137 mM NaCl, 7 mM KCl, 0.7 mM
Na2HPO4, and 10 mM HEPES, adjusted to pH 7.65) containing 0.5 mM
EDTA to remove blood before they were treated with 400 	g/ml collage-
nase in the perfusion buffer. Following isolation, primary hepatocytes
were plated in M199 medium plus GlutaMax (Invitrogen) supplemented
with 10% fetal calf serum (FCS), 1% penicillin-streptomycin, 0.1% bo-
vine serum albumin (BSA), 10 nM insulin, 200 nM triiodothyronine, and
500 nM dexamethasone.
Metabolic studies. Experiments were performed to determine
whether the rates of mitochondrial respiration or glycolysis differed in
Nrf2/ andNrf2/ hepatocytes upon treatment with fatty acids or glu-
cose using a Seahorse Bioscience XF 24 analyzer. Freshly prepared pri-
mary hepatocytes were plated in XF 24-well plates at a density of 1 104
cells per well in M199 medium containing 2 mM GlutaMax, which was
supplemented with 10% FCS, 1% penicillin-streptomycin, 0.1% BSA, 10
nM insulin, 200 nM triiodothyronine, and 500 nM dexamethasone. The
cells were cultured overnight at 37°C before being washed with XF 24
Dulbecco’s modified Eagle’s medium (DMEM) assay medium supple-
mented with 5.5mMglucose and 2mMGlutaMax prior to incubation for
1 h in the same medium (without CO2 preincubation). Thereafter, the
plates were loaded onto an XF 24 analyzer to measure the oxygen con-
sumption rate (OCR) at regular intervals as cells alone (baseline) and after
injecting BSA conjugated with 375	Mpalmitic acid or 375	Moleic acid
in the presence of 1mMcarnitine. The values were normalized against the
total protein content of the cells in each well.
Statistics.Comparisons between the biochemical andmolecular biol-
ogy results from the four experimental groups were made using a paired
or unpaired two-tailed Student’s t test, a one-sample Student’s t test, or
analysis of variance (ANOVA) with a Bonferroni post hoc analysis as ap-
propriate. Analysis of covariance (ANCOVA) was used to examine the
relationship between body weight and oxygen consumption. The results
are means and standard errors of the mean (SEM), and P values of0.05
were considered statistically significant. Comparisons between the histol-
ogy NAS results were made using the Kruskal-Wallis H test.
RESULTS
Whole-bodymetabolic response to ahigh-fat diet ismodifiedby
Nrf2. Nrf2/mice fed an RC diet starting from 8 to 10 weeks of
age did not differ from wild-type mice in average length (data not
shown) or body mass (Fig. 1A); Nrf2/ mice appeared consis-
tently lighter, although this difference did not reach significance.
When fed an HF diet, mass accumulation was less apparent in
Nrf2/mice (Fig. 1B and C), with a mean increase in body mass
of 14.5
 1.3 g (n 10) and 10.7
 1.1 g (n 11; P 0.05) for
Nrf2/ andNrf2/mice, respectively. At 28 weeks of age, qMR
scanning revealed that RC-fed Nrf2/ and Nrf2/ mice had
identical body fat levels and that HF-fed Nrf2/ and Nrf2/
mice increased their relative fat mass, but significantly less for the
Nrf2/mice (Fig. 1D).
Daily food intake was slightly greater for RC-fedNrf2/ than
forNrf2/mice (Fig. 1E), but no difference in food consumption
was observed in HF-fed Nrf2/ and Nrf2/mice by determin-
ing compensatory feeding following an overnight fast (Fig. 1F).
Plasma leptin and insulin levels were similar in RC-fed Nrf2/
and Nrf2/ mice, but consistent with their increased body fat
content, HF-fed Nrf2/ and Nrf2/ mice displayed increased
plasma leptin and insulin levels, with a nonsignificant trend for
reduced leptin levels in Nrf2/mice (Fig. 1G and H). No differ-
ence was observed in the respiratory exchange ratio between
Nrf2/ and Nrf2/mice, though it was lowered by the HF diet
in both (Fig. 1I). Indirect calorimetry showed that Nrf2/ mice
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exhibit higher O2 consumption, indicating that loss of Nrf2 in-
creases energy expenditure (Fig. 1J). HF feeding decreased the
ambulatory activity of Nrf2/ mice in comparison to RC-fed
Nrf2/mice, whereas ambulatory activity was unchanged by diet
in Nrf2/ mice (Fig. 1K). Thus, although Nrf2/ mice display
sensitivity to HF feeding by increasing body fat content, the mag-
nitude of this effect was less than was observed in Nrf2/ mice,
likely due to the increased energy expenditure of Nrf2/mice.
Insulin sensitivity is maintained in Nrf2/ mice fed the
high-fat diet. As NASH is associated with insulin resistance, we
examined glucose homeostasis. On an RC diet, fasting blood glu-
cose levels were similar in Nrf2/ and Nrf2/ mice, and HF
feeding for 16 weeks raised fasted glucose levels in both groups,
indicative of decreased liver insulin sensitivity (Fig. 2A). Although
HF feeding produced a significant increase in fed glucose levels in
both Nrf2/ and Nrf2/ mice, fed glucose levels were lower in
the mutant than in wild-type mice for both RC and HF diets (Fig.
2B). Intraperitoneal glucose tolerance tests (GTT) showed that
RC-fed Nrf2/ and Nrf2/ mice had comparable glucose dis-
posal (Fig. 2C and E), whereas HF-fed Nrf2/ mice displayed
significantly better glucose disposal from the peripheral circula-
tion than diet- and age-matched Nrf2/ mice (Fig. 2D and E).
Also, HF-fed Nrf2/ mice exhibited a greater decrease in blood
glucose during insulin tolerance tests (ITT) thanNrf2/mice, an
outcome not observed for RC-fed mice (Fig. 2F and G); impor-
tantly, the ITT for HF-fed Nrf2/mice had to be curtailed after
60 min, as 50% of them did not mount a counterregulatory
response to insulin-induced hypoglycemia and had to be given
glucose to recover.
To further assess peripheral insulin signaling strength in
Nrf2/ and Nrf2/ mice, we measured the levels of protein
kinase Bphosphorylated at Ser473 (p-PKB; also calledAkt) in liver
and skeletal muscle following intraperitoneal injection of insulin.
In nonstimulated tissues, p-PKB levels did not differ in the two
groups of mice. However, in response to insulin, Nrf2/ mice
displayed significantly higher p-PKB levels in liver and skeletal
muscle than Nrf2/ mice (Fig. 2H and I). Therefore, Nrf2/
mice exhibit greater peripheral insulin sensitivity than Nrf2/
mice, and consequently, when challenged chronically with the HF
diet,Nrf2/mice retain better insulin-mediated glucose disposal
than HF-fed Nrf2/mice.
Nrf2/ mice develop a NASH phenotype when fed a high-
fat diet. Hematoxylin and eosin (H&E) staining of liver sections
was assessed by an expert histopathologist, using the NAS scoring
system developed for human disease. Individual scores for fat,
inflammation, and fibrosis were also analyzed. Livers fromRC-fed
Nrf2/mice showed normal hepatocyte architecture and no ev-
idence of steatosis. However, livers of HF-fedNrf2/mice devel-
oped hepatic steatosis without significant histological evidence of
either inflammation or fibrosis that is consistent with simple ste-
atosis of the human NAFLD spectrum but not with NASH (Fig.
3A and Table 1). Livers fromRC-fedNrf2/mice displayed signs
of microvesicular steatosis but no inflammation. However, livers
fromHF-fedNrf2/mice showed significantmicrovesicular and
macrovesicular steatosis, neutrophil infiltration, apoptotic bod-
ies, and disruption of hepatic architecture that are consistent with
NASH. Cirrhosis was observed only in livers of HF-fed Nrf2/
mice. In conclusion, HF-fed Nrf2/ and HF-fed Nrf2/ livers
contained similar levels of fat that were significantly higher than in
RC-fed Nrf2/ livers, and all contained more fat than RC-fed
FIG 1 Nrf2/ mice on an HF diet exhibit reduced adiposity and higher
energy expenditure than Nrf2/ mice. (A and B) Body mass curves of male
age-matchedNrf2/ andNrf2/mice fed on anRC (A) orHF (B) diet for 20
weeks from 8 weeks of age (10 or 11 mice per group). (C) Body mass gains of
Nrf2/ and Nrf2/ mice fed on an HF diet. (D) Percentages of body fat in
Nrf2/ andNrf2/mice on an RC or HF diet (12 or 13mice per group). (E)
Cumulative food intake of age-matched male Nrf2/ and Nrf2/ mice fed
on RC over a period of 20 weeks (6 mice per group). (F) Food intake after
overnight fast in age-matchedNrf2/ andNrf2/mice fed on an HF diet (5
mice per group). (G and H) Fed plasma leptin (G) and insulin (H) levels from
Nrf2/ andNrf2/mice on anRCorHFdiet (9 to 11mice per group). (I and
J) RER (I) and oxygen consumption (J) (the lines show fitted regressions) for
Nrf2/ and Nrf2/ mice on an RC or HF diet (7 to 13 mice per group). (K)
Effects of genotype and diet on locomotor activity forNrf2/ andNrf2/mice
(7 to 13mice per group). (D,G to I, andK)White bars, RC fed; black bars,HF fed.
The results are means and SEM. *, P 0.05; **, P 0.01; ***, P 0.001.
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Nrf2/ livers. Moreover, the HF-fed Nrf2/ livers had signifi-
cantly more inflammation than any other group. All of these ob-
servations are based upon scores that are relative to each other and
to the normal, rather than absolute values.
Reticulin staining revealed that HF-fed Nrf2/ livers con-
tained significantly increased amounts of type III collagen com-
pared with their RC-fed counterparts and that RC-fed Nrf2/
mouse livers had levels of type III collagen similar to those of
Nrf2/mice on the same diet (data not shown). However, livers
from HF-fed Nrf2/mice contained larger amounts of collagen
than those of HF-fed Nrf2/mice (Fig. 3B). Van Gieson’s stain-
ing of hepatic sections revealed normal levels of collagen inRC-fed
Nrf2/ livers but large increases in collagen deposition inHF-fed
Nrf2/ livers from the central vein through hepatocytes to the
portal triad (Fig. 3C). Increased liver pathology inHF-fedNrf2/
mice was accompanied by elevated plasma ALT activity (Fig. 3D).
qMR analysis revealed that RC-fed Nrf2/ and RC-fed
Nrf2/ livers had comparable levels of fat and that HF feeding
increased fat deposition in both genotypes, with Nrf2/ livers
containing the most fat among the four groups (Fig. 3E). Ultra-
structural analysis showed normal architecture for RC-fed
Nrf2/ livers, with fat globules present in hepatocytes from HF-
fed Nrf2/ and RC-fed Nrf2/ mice, whereas hepatocytes of
HF-fedNrf2/micewere characterized by swollenmitochondria
with reduced crista and disrupted membranes (Fig. 3F). HF feed-
ing did not increase plasma triglycerides or FA levels in either
genotype (data not shown) but increased plasma cholesterol in
both genotypes; Nrf2/ mice exhibited lower cholesterol on ei-
ther diet thanNrf2/mice (Fig. 3G), and this ismost likely due to
inactivation of the redox-sensitive HMG CoA reductase in the
mutant mouse by higher ROS levels (59).
Overall, a clear progression was seen in the animal models
across the NAFLD disease spectrum, with RC-fed Nrf2/ mice
representing normality; RC-fed Nrf2/ mice and HF-fed
FIG 2 Nrf2/mice display improved glucose homeostasis and insulin sensitivity with enhanced skeletalmuscle and liver insulin signaling. (A and B) Fasted (A)
and fed (B) blood glucose levels in Nrf2/ and Nrf2/mice after 16 weeks on an RC or HF diet (5 or 6 mice per group). (C) GTT on Nrf2/ (n 11) and
Nrf2/ (n 9) mice, 28 weeks old, fed RC. (D) GTT on Nrf2/ and Nrf2/mice fed an HF diet for 20 weeks from 8 weeks of age (11 mice per group). (E)
Quantification of the area under the curve (AUC) for the total glycemic excursions shown in panels C and D by genotype and diet. (F) ITT onNrf2/ (n 11)
andNrf2/ (n 9) mice, 28 weeks old, fed RC. (G) ITT onNrf2/ (n 11) andNrf2/ (n 10) mice fed an HF diet for 20 weeks from 8 weeks of age. Note
the curtailed time course of tolerance tests on Nrf2/ mice owing to continual decline in blood glucose and the requirement to intervene with glucose
administration. (H and I) Representative immunoblots of total PKB and insulin-stimulated phosphorylation of PKB (also called Akt) at Ser473 (p-PKB) from the
liver (H) and skeletalmuscle (I) ofNrf2/ andNrf2/mice (7months old) fed RC (10 to 19mice per group). Quantification of the immunoblot data is shown,
and in each case, p-PKB/PKB was normalized with respect to RC-fed Nrf2/ levels. White bars, RC fed; black bars, HF fed. The results are means and SEM. *,
P 0.05; **, P 0.01; ***, P 0.001.
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Nrf2/mice developing steatosis, worse in the latter; andHF-fed
Nrf2/ mice developing the complete NASH phenotype with
fibrosis.We therefore sought, in the experiments described below,
to determine molecular changes that account for the greater de-
gree of NAFLD, inflammation, hepatocellular death, and oxida-
tive stress in mice lacking Nrf2.
Induction of lipogenesis genes by a high-fat diet is accentu-
ated inNrf2/ livers. First, we examined themRNA levels of the
following transcription factors that contribute to liver steatosis:
Srebf1 and Srebf2, which regulate cholesterol biosynthesis;
Mlxipl, which regulates triglyceride synthesis genes in a glucose-
dependentmanner; PPAR, which promotes storage of FA; LXR
and LXR, which control lipid homeostasis and inflammation;
Frx, which regulates cholesterol and bile acid production; and Shp,
which represses LXR(for reviews, see references 60 to64). InNrf2/
livers, the HF diet increased mRNA levels for Srebf1, Srebf2, Mlxip,
PPAR, and LXR but had no significant effect on mRNA for Shp
and reducedmRNAs for LXR andFXR(Fig. 4A). Loss ofNrf2had a
moderate impact on liver expression of these transcription factors,
with a modest increase in Mlxipl and more significant decreases in
mRNAs for Srebf2 and Shp. However, HF-fedNrf2/ livers exhib-
ited significant increases in mRNAs for Srebf1, Srebf2, Mlxipl, and
PPAR, with no change in mRNA for LXR and reduced levels of
mRNAs forShp,LXR, andFXR(Fig. 4A).Westernblotting revealed
that the active form of Srebp-1 (encoded by Srebf1) was most abun-
dant in thenucleiofHF-fedNrf2/ liversbutwasalsoelevated in the
nuclei of RC-fedNrf2/ andHF-fedNrf2/ livers compared with
RC-fedNrf2/ livers (Fig. 4B). Thus, the HF diet increased expres-
sion in the liver of transcription factors that are associated with FA
uptake, FA oxidation, FA storage, lipogenesis, and inflammation in
wild-type andNrf2/mice, but in all cases, the effect was greater in
Nrf2/ than in Nrf2/ livers. Also, the HF diet decreased expres-
FIG 3 Histological and biochemical evidence of steatohepatitis and fibrosis in
the livers ofNrf2/mice fed a high-fat diet. (A) Representative H&E-stained
images of livers fromNrf2/ andNrf2/mice after 24weeks on anRCorHF
diet from 8 to 10 weeks of age. (B and C) Representative images of reticulin
staining (B) andVanGieson’s staining (C) in livers fromNrf2/mice after 24
weeks on an RC or HF diet. Bars, 100 	m. (D) ALT activity in plasma of
Nrf2/ andNrf2/mice after 24weeks on anRCorHFdiet (8 to 11mice per
group). (E) Magnetic resonance analysis of fat content in livers from Nrf2/
and Nrf2/mice on an RC or HF diet (12 or 13 mice per group). (F) Repre-
sentative electron microscope images of liver sections from Nrf2/ and
Nrf2/ mice on an RC or HF diet; bars, 1,731 nm. (G) Cholesterol levels in
plasma fromNrf2/ andNrf2/mice on RC and HF diets (9 to 11 mice per
group). (D, E, and G) White bars, RC fed; black bars, HF fed. The results are
means and SEM. *, P 0.05; **, P 0.01; ***, P 0.001.
TABLE 1 Histology of livers from Nrf2/ and Nrf2/mice fed a
high-fat diet for 24 weeks
Parameter
Valuef (n)
RC diet HF diet
NASa (maximum 8)
Nrf2/mice 0.5 (10) 3.45 (11)
Nrf2/mice 2.0 (9) 4.9 (10)
Steatosis component of NASb (0–3)
Nrf2/mice 0.9 (10) 2.55 (11)
Nrf2/mice 1.33 (9) 2.4 (10)
Inflammatory component of NASc (0–3)
Nrf2/mice 0 (10) 0.82 (11)
Nrf2/mice 0.66 (9) 2.3 (10)
Ballooning component of NASd (0–2)
Nrf2/mice 0 (10) 0 (11)
Nrf2/mice 0 (9) 0.3 (10)
Fibrosis stagee (0–3)
Nrf2/mice 0 (10) 0 (11)
Nrf2/mice 0 (9) 1 (10)
a In Nrf2/mice, the NAS is significantly higher in livers of HF-fed mice than in RC-
fed animals (Kruskal-Wallis H test; P 0.002), and the same is seen in livers of HF-fed
Nrf2/mice compared to RC-fed Nrf2/ livers. The HF-fed Nrf2/mice had a
significantly higher NAS than HF-fed Nrf2/mice (Kruskal-Wallis H test; P 0.03).
b Both HF-fed Nrf2/ and Nrf2/mice had more steatosis than their RC-fed
counterparts (Kruskal-Wallis H test; P 0.03). No significant difference was observed
between Nrf2/ and Nrf2/mice fed the same diet.
c The inflammatory component of the NAS was significantly higher in livers of HF-fed
Nrf2/mice than in either HF-fed Nrf2/ or RC-fed Nrf2/mice (Kruskal-Wallis
H test; P 0.002).
d No statistical differences were observed for ballooning between the experimental
groups.
e The median values are shown, and fibrosis was observed only in livers of HF-fed
Nrf2/mice.
f The significance of differences in the NAS scores of livers from RC-fed and HF-fed
Nrf2/ and Nrf2/mice was assessed using the Kruskal-Wallis H test. The
differences between the NAS results of the 4 experimental groups were highly
significant (Kruskal-Wallis H test; P 0.002), with both HF diet mice having higher
NAS values than their chow-fed counterparts. Moreover, a significant difference was
observed between the two HF-fed groups, with the Nrf2/ animals having the higher
score (Kruskal-Wallis H test; P 0.03), despite the fact that the steatosis components
of NAS were similar in the two HF-fed groups, which blurs the difference in their NAS
results. The difference in the NAS between HF-fed Nrf2/ and Nrf2/ animals is
smaller than the difference in inflammation and the degree of NASH between them;
this represents a limitation of the NAS ranking system, which simply adds the 3
components together. Therefore, the apparent relative increase of steatosis in HF-fed
Nrf2/ livers compared to HF-fed Nrf2/ livers masks the increased inflammation
score in the latter, because hepatocytes lose fat as they become inflamed. Fibrosis, which
is not part of the NAS, was not observed in the livers of RC-fed animals or in HF-fed
Nrf2/ livers, but it was seen in HF-fed Nrf2/ livers (amounting to cirrhosis in 2 of
10 animals).
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sion of FXR, which controls the synthesis of bile acids, as well as the
expression of the nuclear receptor repressor Shp, which is regulated
by Fxr (60), and again, this was most apparent inNrf2/ livers.
Second, mRNAs for proteins involved in lipogenesis were ex-
amined. They includedAcly, which catalyzes production of acetyl-
CoA that is required for lipid biosynthesis; the FA synthesis Acaca
gene, which encodes AccI that produces malonyl-CoA; the FA
synthase Fasn; the FA elongases Elovl5 and Elovl6; the desaturase
Scd1; and the FA uptake and transport proteins Fabp1 and Fabp5
(61, 64). InNrf2/mice, HF feeding increased mRNAs for Acly,
Acaca, Elovl5, Elovl6, Fasn, and Fabp5 but had no effect onmRNA
for Fabp1 and reduced mRNA for Scd1 (Fig. 4C). Livers from
RC-fed Nrf2/ mice showed a modest decrease in mRNA for
Acaca and an increase in Elovl6 and Fabp5, with no change in the
other transcripts. However, HF-fed Nrf2/ livers demonstrated
increases in mRNAs for Acly, Acaca, Fasn, Elovl5, Elovl6, and
Fabp5 that were significantly greater than those observed in HF-
fed Nrf2/ livers but had no effect on Fabp1. The HF diet ap-
peared to downregulatemRNA for Scd1 expression independently
of genotype (Fig. 4C). Thus, while the HF diet increased the ex-
pression of several key enzymes/proteins associated with lipogen-
esis, this induction was accentuated in Nrf2/ livers.
Lipid catabolism genes are downregulated inNrf2/ livers.
Expression of Ppar, which supports uptake, utilization, and ca-
tabolism of FA, was increased in HF-fed Nrf2/ livers (Fig. 4D).
The expression of Ppar in RC-fed Nrf2/ livers was lower than
in wild-type controls. However, induction of Ppar in HF-fed
Nrf2/ livers exceeded that seen in wild-type mice. Similarly,
expression of the Acacb gene, which encodes Acc2 and results in
raised malonyl-CoA, causing inhibition of Cpt1a, the rate-limit-
ing step in FA uptake into mitochondria, was increased by the HF
diet in Nrf2/ livers and to a much greater extent in HF-fed
Nrf2/ livers. In addition, Acacb gene expression was lower in
RC-fed Nrf2/ livers than in RC-fed Nrf2/ livers.
RC- and HF-fedNrf2/ livers had much reduced mRNA lev-
els for Cpt1a, which is required for -oxidation of long-chain FA,
compared to RC-fed Nrf2/ livers, with the HF diet reducing
Cpt1a mRNA in Nrf2/ livers to a much lesser extent than in
Nrf2/ livers (Fig. 4D). The expression of Acaa1, which contrib-
utes to the -oxidation of FA in peroxisomes, was diminished in
FIG 4 Expression ofmany lipid-associated transcription factors and lipogenic enzymes is upregulated inHF-fedNrf2/ livers to a greater extent than inHF-fed
Nrf2/ livers. (A)Quantitative-PCR analysis ofmRNAs for transcription factors that regulate lipid and glucosemetabolism and storage in livers ofNrf2/ and
Nrf2/mice on an RC orHF diet (6 to 12mice per group). (B) Immunoblots of Srebp-1c in nuclear subcellular fractions (nSREBP-1c) and cytosolic subcellular
fractions (cSREBP-1c) from livers of Nrf2/ and Nrf2/mice on an RC or HF diet. (C and D) Quantitative-PCR analysis of mRNA for enzymes involved in
lipogenesis (C) and FA catabolism (D) in livers of Nrf2/ and Nrf2/mice on an RC or HF diet (10 to 12 mice per group). (E) Quantitative-PCR analysis of
mRNA for cytochrome P450 enzymes that oxidize fatty acids in livers ofNrf2/ andNrf2/mice on an RC or HF diet (10 to 12mice per group). In each case,
the data were normalized with respect to RC-fedNrf2/ levels for each gene.White bars, RC fed; black bars, HF fed. The results aremeans and SEM. *, P 0.05;
**, P 0.01; ***, P 0.001.
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HF-fed Nrf2/ livers, but it was further lowered in HF-fed
Nrf2/ livers. Thus, the increased expression of Acacb in HF-fed
Nrf2/ livers, coupled with the exaggerated loss of Cpt1a and
Acaa1 expression, may contribute to the increased hepatic steato-
sis in these animals.
We monitored Cyp isoenzymes that oxidize medium-chain
FA. Loss of Nrf2 had no effect on Cyp2e1 or Cyp4a10 but signifi-
cantly reduced Cyp4a14 expression in livers of RC-fed mice (Fig.
4E). However, theHF diet did not decrease the expression of these
Cyp isoenzymes in Nrf2/ livers to levels lower than those ob-
served inNrf2/ livers, so it seems improbable that they account
for the higher level of steatosis in mutant livers than in wild-type
livers.
Loss of Nrf2 decreases inhibitory phosphorylation of acetyl-
CoA carboxylase.The above-mentioned data indicate theHF diet
combinedwith loss ofNrf2 results in decreased hepaticmitochon-
drial and peroxisomal FA oxidation. One consequence of lowered
FA -oxidation is reduced ketogenesis (82). Consistent with this
prediction, RC- andHF-fedNrf2/mice exhibited lower plasma
-hydroxybutyrate levels than similarly fed Nrf2/ mice (Fig.
5A). FA -oxidation is regulated by AMPK. Activation of mouse
Ampk arises from phosphorylation of Thr172 in its -subunit,
which can lead subsequently to inactivation of AccI and Acc2 by
phosphorylation at Ser79 and Ser218, respectively. In turn, inhi-
bition of AccI and Acc2 increases levels of malonyl-CoA, which is
a substrate for Fasn and a potent allosteric inhibitor of Cpt1a.
Immunoblotting revealed no difference in AccI and/or Acc2 pro-
tein (referred to here asAcc) levels by diet or genotype but reduced
levels of Ampk protein in Nrf2/ livers (Fig. 5B and C). More-
over, the amounts of phosphorylated Acc (p-Acc) and Ampk (p-
Ampk) were reduced in Nrf2-null livers, regardless of diet, with
the p-Acc/Acc ratio severely diminished in Nrf2/ compared to
Nrf2/ livers for both diets. In contrast, the p-Ampk/Ampk ratio
was unaltered by genotype and diminished by HF feeding in both
Nrf2/ and Nrf2/mouse livers. Thus, loss of Nrf2 diminishes
the phosphorylation status of Acc, strongly suggesting elevation in
its activity and greater production of malonyl-CoA, an important
FA building block and an inhibitor of FA oxidation.
Nrf2 influences the utilization of glucose and fatty acids in
hepatocytes.Wenext examined the ability of primary hepatocytes
from Nrf2/ and Nrf2/mice to utilize glucose and FA as sub-
strates. Nrf2-null hepatocytes possessed a significantly lower basal
glucose oxidation rate and were less able to oxidize palmitate or
oleate than Nrf2/ hepatocytes (Fig. 5D). Treatment of Nrf2/
hepatocytes with the AMPK activator AICAR or Abbott (A-
769662) increased their ability to oxidize palmitate and oleate,
proportionally equivalent to that observed for Nrf2/ hepato-
cytes (Fig. 5E). Together, these results indicate that loss of Nrf2
severely diminishes oxidation by the liver of glucose and FA and
that this is partly due to a reduction in hepatic Ampk activity in the
mouse liver.
The UPR is perturbed in Nrf2-null mouse liver under basal
conditions. InNrf2/ livers, the HF diet stimulated a substantial
increase in the ER-resident stress sensor proteins Perk and Ire1
(Fig. 6A). Also, an increase in Atf6 p90 but not Atf6 p50 was
observed, suggesting the HF diet did not activate the ATF6 path-
way in wild-type livers. Stimulation of Perk and Ire1 in Nrf2/
livers was associated with induction of Chop and the spliced
mRNA form Xbp1s but not Gadd34 (Fig. 6A and B). Remarkably,
in RC-fed Nrf2/ livers, substantial increases in Xbp1s and Atf6
FIG 5 Loss of Nrf2 diminishes phosphorylation of acetyl-CoA carboxylase and
decreases the oxidation of free fatty acids. (A) Plasma-hydroxybutyrate levels in
Nrf2/ andNrf2/mice on an RC or HF diet (9 to 11 mice per group). White
bars, RC fed; black bars, HF fed. (B) Representative immunoblots for Acc, p-Acc,
Ampk, and p-Ampk, with actin as a loading control, from livers of Nrf2/ and
Nrf2/miceonanRCorHFdiet. (C)Quantificationof the immunoblotdata for
panel B, with p-Ampk/Ampk and p-Acc/Acc ratios (9 or 10mice per group). The
data were normalized with respect to RC-fed Nrf2/ levels for each protein or
ratio. White bars, RC fed; black bars, HF fed. (D) OCRs for primary hepatocytes
obtained from livers ofNrf2/ (n 3) andNrf2/ (n 4) mice on RC diets,
presented with the following substrates: glucose alone (Glu), followed by glucose
plus palmitate (Glu Pal) or glucose oleate (Glu Ole). (E) Fold change in
OCR on addition of Pal or Ole for primary Nrf2/ and Nrf2/ hepatocytes
treated or not with AICAR or A-769662. The results are means and SEM. *, P
0.05; **, P 0.01; ***, P 0.001.
Meakin et al.
3312 mcb.asm.org Molecular and Cellular Biology
p50 were observed, suggesting that the Ire1 and Atf6 ER stress
pathways are activated in the mutant mice even under basal con-
ditions. In addition, a modest increase in p-eIF2, and a more
obvious increase in Chop, was observed in RC-fed Nrf2/ livers
suggesting that the PERK pathway was also activated, though a
decrease in p-Perk and Ire1 was observed relative to the wild-type
control. Surprisingly, livers from HF-fed Nrf2/ mice did not
exhibit an overt UPR, as evidenced by failure to increase mRNA
and/or protein levels of Atf6 p90, Ire1, Atf4, Atf6 p50, Grp78, and
Xbp1s compared with HF-fed Nrf2/ and/or RC-fed Nrf2/
livers, and we suppose this failure occurs either because the UPR
cannot be maintained as a consequence of extensive liver damage
or because triggering of the UPR is fundamentally altered in
Nrf2/ livers. The only exception to this trend was the observa-
tion that ChopmRNA levels were slightly increased in the livers of
HF-fed Nrf2/mice (Fig. 6B).
Loss of Nrf2 exacerbates inflammation in the liver caused by
a high-fat diet. As activation of PERK and IRE1 during ER stress
can stimulate inflammatory responses mediated by NF-B and
JNK (15, 16), we evaluatedwhether theHFdiet differentially stim-
ulates inflammatory responses in wild-type and Nrf2/ livers.
First, we measured Mpo, because it is indicative of activated
Kupffer cells (65). The HF diet increased Mpo mRNA in both
genotypes, with loss of Nrf2 significantly enhancing Mpo expres-
sion under both dietary regimes (Fig. 7A). In Nrf2/ livers, the
HF diet increased mRNAs for the inflammatory markers IL-1
and TNF-, though it modestly decreased that for IL-6 (Fig. 7B).
Compared to wild-type control livers, RC-fed Nrf2/ livers ex-
hibited no increase in TNF-, IL-1, and IL-6 expression. How-
ever, the HF diet induced their expression to levels significantly
higher than it did in Nrf2/ mice, suggesting an exacerbated
inflammatory response in the knockout mice (Fig. 7B).
The nuclear abundance of the NF-B p65 RelA subunit was
increased in livers of HF-fed Nrf2/ and RC-fed Nrf2/ mice,
with the HF diet raising NF-B p65 levels in Nrf2/ livers even
further (Fig. 7C). The HF diet also produced pronounced in-
creases in RelA mRNA inNrf2/mice (Fig. 7C). The expression
of theNF-B target genesCox2 andNos2was increased by 12- and
6-fold, respectively, in HF-fed Nrf2/ livers and by 23- and 60-
fold, respectively, in livers of HF-fed Nrf2/mice (Fig. 7D). We
FIG 6 ER stress pathways are perturbed in the livers ofNrf2/mice. (A) Representative immunoblots from analysis of ER stress and UPR-associated proteins
in livers ofNrf2/ andNrf2/mice on an RC or HF diet. Quantification of the immunoblot data for each protein is shown by genotype and diet (3 mice per
group). (B) Quantitative-PCR analysis of mRNAs of ER stress markers from livers ofNrf2/ andNrf2/mice on RC and HF diets (5 to 8 mice per group). In
each case, the data were normalizedwith respect to RC-fedNrf2/ levels for each protein and gene.White bars, RC fed; black bars, HF fed. The results aremeans
and SEM. *, P 0.05; **, P 0.01; ***, P 0.001.
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also measured JNK activation. As expected, p-JNK levels were
increased by the HF diet in Nrf2/ livers and were elevated in
RC-fed Nrf2/ livers. Significantly, p-JNK levels were highest in
Nrf2/ livers (Fig. 7E).
As Nos2 was highly expressed in HF Nrf2/ livers, it is possi-
ble that excessive nitric oxide levels contribute to inflammation.
We therefore examined the possibility that nitrotyrosine levels
were high in livers fromNrf2/mice. As anticipated, staining for
nitrotyrosine was greater in HF Nrf2/ livers than in the other
livers examined (Fig. 7F).
Collectively, these results indicate that the HF diet stimulates a
mild inflammatory response in livers of Nrf2/mice. However,
Nrf2/mice exhibited mild liver inflammation even under basal
conditions, and this was markedly aggravated by the HF diet.
Livers from high-fat-fed Nrf2/mice are subject to oxida-
tive stress and hepatocellular injury. We examined whether the
HF diet provokes oxidative stress in the liver by measuring GSH,
GSSG, MDA, and the levels of oxidized protein. InNrf2/mice,
the HF diet produced an increase in GSSG (Fig. 8A) and MDA
(Fig. 8B), but no change was observed in protein carbonyl lev-
els, suggesting that the extent of oxidative stress in wild-type
mice was not sufficient to cause irreversible damage (Fig. 8C).
In comparison, the livers of RC-fed Nrf2/ mice contained
significantly increased GSSG (Fig. 8A), but the levels of MDA
and protein carbonyls did not differ from those in RC-fed
Nrf2/ livers. Most strikingly, the HF-fed Nrf2/ livers con-
tained elevated GSSG and large increases in MDA and protein
carbonyls compared with either RC- or HF-fed Nrf2/ mice
FIG 7 A high-fat diet elicits an exaggerated inflammatory response in the livers of Nrf2/mice. (A) Quantitative-PCR analysis of mRNA for Mpo in livers of
Nrf2/ and Nrf2/ mice on an RC or HF diet (10 to 12 mice per group). (B) Quantitative-PCR analysis of levels of mRNAs for the inflammatory markers
TNF-, IL-1, and IL-6 in livers ofNrf2/ andNrf2/mice on an RC orHF diet (10 to 12mice per group). (C) Representative immunoblots for nuclear levels
of the p65 subunit of NF-B in livers ofNrf2/ andNrf2/mice on an RC or HF diet. PCNAwas used as a loading control. Quantification of the immunoblot
data for NF-B p65 is shown (6 mice per group), along with quantitative-PCR analysis of mRNA for RelA (10 to 12 mice per group). (D) Quantitative-PCR
analysis of mRNAs for the NF-B Cox2 and Nos2 target genes in livers of Nrf2/ and Nrf2/ mice on an RC or HF diet (10 to 12 mice per group). (E)
Representative immunoblot for phosphorylated JNK (p-JNK) and total JNK in livers of Nrf2/ and Nrf2/mice on an RC or HF diet. Quantification of the
immunoblot data for p-JNK is shown (3mice per group). (F) Staining for nitrotyrosine in liver sections fromNrf2/ andNrf2/mice on anRCorHF diet (the
arrows indicate cells giving a positive nitrotyrosine stain; bars, 100 	m). In each case, the data were normalized with respect to RC-fed Nrf2/ levels for each
protein or gene. White bars, RC fed; black bars, HF fed. The results are means and SEM. *, P 0.05; **, P 0.01; ***, P 0.001.
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(Fig. 8A to C), indicating that the higher oxidative-stress load
produced by the HF diet in the mutant mouse exceeded its
intrinsic antioxidant capacity.
TheNrf2/ livers exhibited evidence of apoptosis and necro-
sis. Thus, in HF-fedNrf2/ livers but not HF-fedNrf2/ livers,
increases in cleavedcaspases3and9wereobserved, aswas an increase
in a marker for DNA double-strand breaks, p-H2AX (Fig. 8D). RC-
fed Nrf2/ mouse livers also demonstrated evidence of apopto-
sis, with increased levels of cleaved caspases 3 and 9 and p-H2AX.
TUNEL analysis revealed a marked increase in DNA fragmenta-
tion in HF-fed Nrf2/ and RC-fed Nrf2/ livers and that
cleaved DNA was present in the cytoplasm of a substantial num-
ber of hepatocytes (Fig. 8E). This pattern of staining is consistent
with necrotic cell death andwas observed to amuch greater degree
in HF-fed Nrf2/ livers. Immunoblotting for the nuclear non-
histone protein HMGB1 in cytosolic fractions also suggested re-
lease in RC- and HF-fedNrf2/ livers of nuclear protein into the
cytoplasm, which suggests loss of nuclear membrane integrity in a
significant portion of hepatocytes that lack Nrf2 (Fig. 8F).
Nrf2/ livers fail to adapt tohigh-fat diet-stimulatedoxida-
tive stress. Consistent with the notion that the HF diet elicits an
antioxidant response (37, 39), mRNA levels for the cystine/gluta-
mate antiporter Slc7a11 and the Gclc and Gclm subunits, which
together catalyze the rate-limiting step in glutathione synthesis,
were increased in HF-fed Nrf2/ livers (Fig. 9A). An increase in
mRNA for Gsr1, which catalyzes reduction of GSSG to GSH, was
not observed. The HF diet also increased the amount of Gclc pro-
tein but not Gclm protein inNrf2/ livers (Fig. 9B). In contrast,
RC-fed Nrf2/ livers contained smaller amounts of mRNA for
Gclc and Gclm than theirNrf2/ counterparts, and also reduced
levels of Gclc protein, with diminished or no increase following
administration of theHF diet, suggesting that the basal expression
of these genes is compromised in the mutant mice and that they
mount a blunted antioxidant response. An exception to this out-
come was the level of Gclm protein, which was relatively un-
changed by genotype and exhibited a small increase in response to
theHF diet. The failure of Gclm protein to reflect changes inGclm
mRNA is probably due to posttranscriptional regulation of the
FIG 8 The livers ofNrf2/mice fed a high-fat diet are subject to oxidative stress and exhibit an increased level of apoptosis andDNAdamage. (A) Ratio ofGSSG
to GSH in the livers ofNrf2/ andNrf2/mice on an RC or HF diet (6 mice per group). (B) Lipid peroxidation product MDA levels in livers ofNrf2/ and
Nrf2/ mice on an RC or HF diet (8 mice per group). (C) Levels of oxidized protein shown as a representative OxyBlot using 20 	g of protein from each
experimental group. Lanes: 1, molecular weight standard; 2, 4, 6, and 8, negative controls (no 2,4-dinitrophenylhydrazine); 3, RC-fed Nrf2/; 5, RC-fed
Nrf2/; 7,HF-fedNrf2/; 9,HF-fedNrf2/. The graph shows densitometricmeasurements of lanes 3, 5, 7, and 9 (normalized to theRC-fedNrf2/ amount)
in livers ofNrf2/ andNrf2/mice on an RC or HF diet (8 to 11 mice per group). (D) Representative immunoblots of full-length (FL) and cleaved caspase 9
and caspase 3 and phosphorylated H2AX in livers ofNrf2/ andNrf2/mice on an RC or HF diet. (E) DNA fragmentation in livers ofNrf2/ andNrf2/
mice on an RC or HF diet was examined by TUNEL assay (the arrows indicate apoptotic/necrotic cells; bars, 100 	m), with the mean percentages of TUNEL-
positive cells shown (5mice per group). (F) Immunoblot for HMGB1 in nuclear and cytosolic fractions ofNrf2/ andNrf2/ livers fromRC- orHF-fedmice.
Quantification of the immunoblot data for each protein is shown by genotype and diet (3 mice per group). In each case, the data were normalized with respect
to RC-fed Nrf2/ levels for each protein. White bars, RC fed; black bars, HF fed. The results are means and SEM. *, P  0.05; **, P  0.01; ***, P  0.001.
Molecular mass markers (C, D, and F) are in kDa.
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FIG 9 A high-fat diet stimulates an antioxidant response in Nrf2/ livers that is attenuated in Nrf2/ livers. (A) Quantitative-PCR analysis of mRNAs for
glutathione homeostasis genes in livers ofNrf2/ andNrf2/mice on an RC orHF diet (7 to 12mice per group). (B) Representative immunoblots of Gclc and
Gclm proteins in livers ofNrf2/ andNrf2/mice on an RC orHF diet. Quantification of the immunoblot data for each protein is shown by genotype and diet
(3 mice per group). (C) Quantitative PCR of mRNAs for Txnrd1 and Srxn1 in livers of Nrf2/ and Nrf2/mice on an RC or HF diet. (D) Quantitative PCR
of mRNA for “prototypic” ARE-driven genes from livers of Nrf2/ and Nrf2/ mice on an RC or HF diet (10 to 12 mice per group). (E) Representative
immunoblots ofGsta4, Gstm1-2, andGsta1-2 in livers ofNrf2/ andNrf2/mice on anRCorHFdiet.Quantification of the immunoblot data for each protein
is shown by genotype and diet (3 mice per group). (F) Representative immunoblots of Nqo1 and Hmox1 in livers ofNrf2/ andNrf2/mice on an RC or HF
diet. Quantification of the immunoblot data for each protein is shown by genotype and diet (6 mice per group). In each case, the data were normalized with
respect to RC-fedNrf2/ levels for each protein or gene. White bars, RC fed; black bars, HF fed. The results are means and SEM. *, P 0.05; **, P 0.01; ***,
P 0.001. Molecular mass markers (B, E, and F) are in kDa.
Meakin et al.
3316 mcb.asm.org Molecular and Cellular Biology
subunit, but at present, no definitive explanation exists for this
anomaly. The hypothesis that Nrf2/ livers have less intrinsic
antioxidant capacity than Nrf2/ livers is supported by the fact
that levels of mRNAs for Txnrd1, which reduces oxidized thiore-
doxin, and Srxn1, which reactivates overoxidized peroxiredoxin,
are significantly lower in RC- andHF-fedNrf2/ livers (Fig. 9C).
To examine whether the HF diet induces prototypic ARE-
driven genes, we measured Gst subunit mRNA levels and Gst,
Nqo1, and Hmox1 proteins. In Nrf2/ livers, the HF diet pro-
duced 2- to 3-fold increases in mRNA levels for Gsta1, Gsta2,
Gsta4, Gstm1, and Gstm2 and similar increases in the amounts of
Gsta1/2, Gsta4, Gstm1/2, Hmox1, and Nqo1 proteins (Fig. 9C to
E), suggesting that livers of wild-type mice can adapt to the oxi-
dative stress presented by consumption of an HF diet. As ex-
pected, in RC-fed Nrf2/ mouse livers, levels of these mRNAs
and proteins were lower than in RC-fedNrf2/ livers, indicating
that Nrf2 controls their basal expression. However, the HF diet
stimulated amodest induction of themajority of these genes in the
mutant mice, albeit from a lower basal level (Fig. 9D to F), sug-
gesting that Nrf2/ livers are intrinsically more sensitive to oxi-
dative stress and are less able to adapt to such insult.
DISCUSSION
NASH may arise through a “two-step” process in which insulin
resistance first produces steatosis and subsequently oxidative
stress drives inflammation (66, 67). As loss of Nrf2 increases both
expression of lipogenesis genes and sensitivity to oxidative stress,
it seems likely to contribute to the etiology ofNASH.We therefore
examined whether Nrf2/ mice become insulin resistant when
fed an HF diet and whether this results in their being more sensi-
tive than wild-type mice to developing NASH.
The development of NASH inNrf2/mice does not require
insulin resistance.Upon HF feeding, we foundNrf2/mice ex-
hibit partial protection against obesity, increased energy expendi-
ture, and better glucose disposal and insulin sensitivity than HF-
fed Nrf2/ mice. Such outcomes, although conflicting with the
majority of Nrf2 gain-of-function studies (37, 68, 69), are in
agreement with other recent studies of long-termHF-fedNrf2/
mice (39, 43). The increased strength of insulin signaling in both
Nrf2/ livers and skeletal muscle possibly reflects impaired anti-
oxidant capacity in themutant animal that results in an increase in
H2O2 levels, which in turn increases inactivation of protein ty-
rosine phosphatase 1B that antagonizes insulin signaling (70). The
situation in Nrf2/ mice may resemble that in glutathione per-
oxidase 1 knockoutmice, where a relative decrease in the ability to
eliminate H2O2 enhances insulin sensitivity (71). Although fur-
ther work is required to demonstrate why HF-fed Nrf2/ mice
are more sensitive to insulin than their wild-type counterparts,
our study demonstrates clearly that insulin resistance is not a pre-
requisite for NASH inNrf2/mice. This is an unexpected result,
because it is commonly believed that ER stress and inflammation,
both of which occur in Nrf2/ livers, are inexorably linked to
insulin resistance (16).
Steatosis inNrf2/mice is associatedwithmultiple changes
in lipidmetabolism genes.The greater degree of steatosis in livers
of Nrf2/ mice fed the HF diet for 24 weeks than in livers of
similarly treated Nrf2/mice is multifactorial. In part, it proba-
bly arises because the mutant animals upregulate the FA uptake
protein Fabp5 and the FA synthesis enzymes Acly, Acaca, Fasn,
and Elovl6 to a greater extent than Nrf2/ mice. It is also likely
that the greater decrease in Cpt1a, which is rate limiting for FA
-oxidation, in Nrf2/ livers than in Nrf2/ livers contributes
to increased steatosis in the mutant animals.
The heightened upregulation of Fabp5, Acly, Acaca, Fasn, and
Elovl6 in Nrf2/ livers in response to the HF diet is likely to be
due to the increased expression of the transcription factors Srebf1,
Srebf2, Mlxipl, and PPAR compared with that in HF Nrf2/
livers. Furthermore, decreased expression of Shp, which inhibits
the cholesterol and FA homeostasis transcription factor LXR,
may also contribute to steatosis. Consistent with the latter idea,
Kay et al. (45) reported that loss of Nrf2 greatly exacerbates stim-
ulation of NASH by the LXR agonist T0901317, whereas activa-
tion of Nrf2 by administration of sulforaphane inhibited NASH
caused by the LXR agonist. Indeed, they proposed that activation
of Nrf2 resulted in FXR-mediated induction of Shp, which subse-
quently inhibited LXR by forming an inactive LXR-Shp het-
erodimer, and prevented T0901317 from stimulating NASH.
AMPK signaling is impaired inNrf2/mice.Anunexpected
finding was that Acc is no longer subject to inhibitory phosphor-
ylation in the livers of RC- and HF-fed Nrf2/mice. The result-
ing increase in Acc is likely to augment malonyl-CoA levels, thus
driving lipogenesis and decreasing FA oxidation. This was a sur-
prising result, because AMPK, the kinase predominantly respon-
sible for inhibitory Acc phosphorylation, is activated by H2O2
through phosphorylation by LKB1 (72, 73), and it is probable that
H2O2 is more abundant inNrf2
/ than inNrf2/ livers. Immu-
noblotting suggested that the lack of Acc phosphorylation in
Nrf2/ livers results from reduction in AMPK activity. However,
treatment with the AMPK activators AICAR and A-769662 en-
hanced the ability of Nrf2/ hepatocytes to oxidize FA, suggest-
ing the kinase can be activated in livers from knockout mice. Fur-
ther work is required to establish how Nrf2 regulates this kinase.
Intriguingly, the findings that Ampk1/ mice are protected
from HF diet-induced steatosis (74) and that Ampk1 (i.e.,
Prkab1) is upregulated in Nrf2/ mice (31) suggest that it may
contribute to exacerbation of steatosis in Nrf2/ liver. Further-
more, reduced Ampk activity in Nrf2/ livers also results in in-
creased activity of Srebp-1c and Srebp-2, which drive lipogenesis.
Nrf2 suppresses ER stress and inflammation. We found that
Xbp1s, Chop, p-elf2, and Atf6 protein levels and Chop, Xbp1,
and Grp78 transcripts are upregulated in the livers of RC-fed
Nrf2/ mice, suggesting they may experience ER stress under
basal conditions. It has not been reported previously thatNrf2/
livers are subject to ER stress, but as we examinedmice that are 32
to 34 weeks of age, it is possible this phenotype is apparent only in
older mice, not the younger animals that are more commonly
studied. Notably, Nrf2/ fibroblasts have previously been re-
ported to upregulate Chop under basal conditions (75), which
agrees with our findings.
As ROS facilitates triggering of the UPR, and the antioxidant
butylated hydroxyanisole can reduce ER stress (76, 77), itmight be
anticipated that Nrf2/ mice are susceptible to ER stress. Evi-
dence suggests that the UPR, along with ROS and release of Ca2
from the ER, is linked to inflammation through activation of
NF-B and JNK (15, 16). Therefore, the increase in NF-B and
p-JNK proteins and expression of Cox2 and Nos2 in RC-fed
Nrf2/ livers is likely partly due to constitutive activation of the
UPR in livers of mutantmice. Furthermore, the overexpression of
Chop in Nrf2/ livers may contribute to metabolic dysregula-
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tion, inflammation, and fibrosis, as these conditions have been
linked to increased Chop levels in the mouse (78).
Our finding that the nuclear protein HMGB1 is present in the
cytosolic fraction ofHFNrf2/ livers is interesting, because upon
release from cells, it can function as a damage-associated molecu-
lar-pattern polypeptide that contributes to inflammatory pro-
cesses (79, 80). Importantly, signaling byHMGB1 is influenced by
its redox status, and this might be expected to differ markedly in
Nrf2/ and wild-type mice.
Surprisingly, in HF-fed Nrf2/ livers there was an overall re-
duction in the levels of ER stress markers. This apparent failure to
maintain the UPR in livers of HF-fed Nrf2/ mice might be as-
sociated with chronic damage owing to the duration of the exper-
iment. Further experiments are required to allow the time course
of HF diet-stimulated ER stress in wild-type andNrf2/ livers to
be documented.
Concluding comments. The results presented here show that
knockout of Nrf2 renders mice more sensitive to NASH when
placed on an HF diet. Our data indicate that the increase in ste-
atosis inNrf2/mice placed on theHF diet is due to a heightened
level of induction of lipogenesis genes and suppression of -oxi-
dation genes comparedwithwild-type animals. Administration of
the HF diet stimulated hepatic oxidative stress, and as livers of
Nrf2/ mice are unable to adapt to such insults, this leads to
failure to maintain normal homeostatic levels of the glutathione-
and thioredoxin-based antioxidant systems, which may stimulate
inflammation. Unexpectedly, we found that the UPR is perturbed
in the livers of Nrf2/ mice on the RC control diet, suggesting
that ER stress is triggered in these animals even under basal con-
ditions. It is therefore possible that disturbance of the UPR in the
livers of Nrf2/ mice contributes to the rapid development of
NASH when they are placed on an HF diet. In humans, promoter
polymorphisms exist in the NRF2 gene (NFE2L2) that alter its
activity (81), and it will be interesting in the future to determine
whether they influence lipid metabolism, oxidative stress, inflam-
mation, or ER stress in humans.
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